Hangzhou Yushu Technology Co., Ltd. recently added a new court announcement. The plaintiff is Hangzhou Luweimei Daily Chemical Co., Ltd. The cause of the case is a dispute over infringement of invention patent rights. The case will be heard in the Hangzhou Intermediate People's Court on August 26.

Industrial and commercial information shows that Hangzhou Luweimei Daily Chemical Co., Ltd. was established in June 2005. Its legal representative is Zhou Jianjun, with a registered capital of 550,000 yuan. Its business scope covers online sales of food, agricultural and sideline products, and daily necessities sales. It is jointly held by Zhou Jianjun and Xu Yan. Intellectual property information shows that the company has applied for patents for "an electronic dog" and "an intelligent conference system", of which "an electronic dog" has been authorized.

It is worth noting that this is the first time that Yushu Technology has faced litigation related to invention patents.The company is currently involved in only two lawsuits, the first being a non-compete dispute: In May 2022, Lin sued Yushu Technology, but later withdrew the lawsuit and was approved by the court in July of the same year.

Founded in 2016, Yushu Technology is committed to the research, development, production and sales of consumer-grade and industrial-grade high-performance leg-foot robots, humanoid robots, six-axis robotic arms and other products.At this summer's Davos Forum, the company's founder Wang Xingxing revealed that in the early days of the company, there was only one person. The team has now grown to about 1,000 people, with annual revenue exceeding 1 billion yuan.

In July this year, Yushu Technology started the listing counseling process, and the counseling agency was CITIC Securities. According to the filing report, the company’s actual controller Wang Xingxing directly holds 23.8216% of the equity and controls 10.9414% of the equity through Shanghai Yuyi Enterprise Management Consulting Partnership (Limited Partnership), totaling 34.7630% of the company’s equity.